Replies to post #340183 on Anavex Life Sciences Corp (AVXL)

[nidan7500]

tredenwater2:

True dat! Not only has the data fromPDD and RS been delayed but so has the roll out of 4 trials. Could it be that this “soup” has new learned data that has new endpoints which are being designed by the company and the Fda in these 4 new trials. It would follow the pattern of learning, the leaps and bounds, trial over trial always building, learning, and implementation of applied knowledge.

No worries here about timing as the “B team” said it best, “ everyday of nonews moves us closer to data release!” When “it” comes its gonna be a whopper cause we all know TGD cant sit on bad data aannnnnd…good data from the PDD and early RS adult has been shared!

WGT!!!!!

You hit the key point..."implementation of applied knowledge."...not the same as decades of FDA "Amyloid plaque...or die trying", (example) farce we have all paid for .

If we don't GOT THIS now, we will eventually. The WS folks need to just hold their water until we say ...GO, b/c it will happen.

[Gernee20]

Could it be that this “soup” has new learned data that has new endpoints which are being designed by the company and the Fda in these 4 new trials.

I suspect the foundation researchers are eager to see Avatar data as well, perhaps to confirm endpoints but simply to confirm their commitment and potential funding from their respective organization(s). These will be large investments from the foundations. Additionally, Missling previously said they are not disclosing the new indication because they were deciding between multiple potential indications. I think the Avatar data delay is the reason for the new trial delays, either because anavex needs the data to proceed, or possibly because the foundations need the data to be 100% committed.

Avatar data that isnt so great could mean different indications flip flop in a ranking of trial priority - which could be determined by Anavex, the foundations, or likely both. If Avatar readout is good/great, I would suspect the undisclosed indication turns into indications - plural.